The Journal of the International Society of Physical and Rehabilitation Medicine

ORIGINAL ARTICLE
Year
: 2021  |  Volume : 4  |  Issue : 4  |  Page : 184--190

Effect of activities of daily living on quality of life among Japanese adults with duchenne muscular dystrophy: A cross-sectional study


Takako Saotome1, Masanori Nojima2, Satoru Iwase3, Hirofumi Komaki4,  
1 Department of Rehabilitation Medicine, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan
2 Center for Translational Research, Institute of Medical Science Hospital, The University of Tokyo, Japan
3 Division of Palliative Medicine, Department of General Internal Medicine, Saitama Medical University, Saitama, Japan
4 Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan

Correspondence Address:
Takako Saotome
Department of Rehabilitation Medicine, Tokyo Metropolitan Neurological Hospital, 2-6-1, Fuchu, Tokyo 183-0042,
Japan

Abstract

Objectives: This study aimed to evaluate the relationship between activities of daily livings (ADLs) and psychological distress along with the quality of life (QOL) in Japanese adults with Duchenne muscular dystrophy. Patients and Methods: This study surveyed 36 adults using the Functional Independence Measure (FIM), the 36-Item Short-Form Health Survey (SF-36 v2) version 2.0, World Health Organization QOL-26, and Hospital Anxiety and Depression Scale. Results: No significant correlation was observed between the FIM scores and scores for all three scales (R <,0.2,for every item). Conclusions: ADLs did not correlate significantly with psychological distress or QOL without considering independent demographic characteristic factors



How to cite this article:
Saotome T, Nojima M, Iwase S, Komaki H. Effect of activities of daily living on quality of life among Japanese adults with duchenne muscular dystrophy: A cross-sectional study.J Int Soc Phys Rehabil Med 2021;4:184-190


How to cite this URL:
Saotome T, Nojima M, Iwase S, Komaki H. Effect of activities of daily living on quality of life among Japanese adults with duchenne muscular dystrophy: A cross-sectional study. J Int Soc Phys Rehabil Med [serial online] 2021 [cited 2022 Jan 28 ];4:184-190
Available from: https://www.jisprm.org/text.asp?2021/4/4/184/329471


Full Text



 Introduction



Duchenne muscular dystrophy (DMD) is a rare X-linked disease.[1] Advances in treatment have increased the life expectancy. The skill levels of activities of daily living (ADLs) in adults with DMD have not been exclusively studied. There seems to be no agreement whether depression and anxiety are present in adolescents and adults with DMD.[2],[3] A multinational study measured health-related quality of life (HRQOL) in the DMD population;[4] however, QOL measures in Japanese adults with DMD are unknown. This study aimed to investigate the current state of Japanese adults with DMD and analyze the relationship of ADLs with QOL and psychological state.

 Patients and Methods



The study was approved by the Institutional Review Board of National Center of Neurology and Psychiatry, National Center Hospital of Neurology and Psychiatry that specializes in the treatment of neuromuscular diseases (A2015-095). The data for this study were collected between March 2016 and March 2018. All study procedures were conducted according to the principles of the World Medical Association Declaration of Helsinki.

Study design and patients

This was a cross-sectional observational study.

Participants were male patients with DMD over 20 years of age who were referred to our department by neurologists or pediatric neurologists at the hospital. Inclusion criteria were the ability to provide conscious consent for participation and no developmental and/or intellectual disorders that could be considered a confounding factor.

Data collection

Demographic characteristics of study participants were obtained from medical records. Collected information included age, age at the time of diagnosis, duration of disease, age at loss of ambulation, management of steroids, cardiovascular medication, status of respirator use, feeding pathway, history of surgical treatment for scoliosis, educational background, and living situation [Table 1].{Table 1}

In one earlier study,[5] the Functional Independence Measure (FIM) was used to assess patients' ADLs.[6],[7],[8],[9] To examine the emotional state of patients, the Japanese version of the Hospital Anxiety and Depression Scale (HADS) has been used.[10] In several previous studies,[3],[11] the 36-item Short-Form Health Survey (SF-36)[12] and the World Health Organization QOL Scale (WHOQOL-BREF)[13] were used to assess QOL. These studies were based on an opinion expressed by Huang et al.,[14] that the SF-36 could be used to measure the health-related perceived status, capabilities, and functioning as an HRQOL measurement and that the WHOQOL-BREF could be used to assess the self-satisfaction and a global QOL measurement. To calculate the overall domain score for WHOQOL-BREF, the raw item scores for each domain were used. A transformed score with the score range 4–20 was obtained by converting the domain score. This method of converting the raw scores to a transformed score was demonstrated by the WHOQOL group.[15] Item 1 measured overall QOL and Item 2 measured general health (GH). In this study, the Japanese versions of the 36-Item Short-Form Health Survey version 2.0 (SF-36 v2)[16] and WHOQOL-BREF (WHOQOL26)[17] were used to assess HRQOL and global QOL.

After obtaining each participant's consent, an investigator assessed each patient to determine the FIM score. If a patient was able to independently complete the questionnaires, an investigator collected the forms in 2–3 days for inpatients or at the time of the next outpatient visit. If a patient was unable to write responses, an investigator recited each question for the patient and recorded the spoken reply.

Statistical analysis

Spearman's correlation analysis was performed to measure the association among each variable of the FIM (total, motor, and cognitive), QOL (the item scores of SF-36 v2 and the domain scores of WHOQOL26), and HADS (anxiety for HADS-A and depression for Hospital Anxiety and Depression Scale Depression subscale [HADS-D]).

For SF-36 v2, the score values were compared to age-adjusted values of Japanese national norms using Welch's one-sample t-test. P <0.05 was considered statistically significant. Data analysis was performed using SPSS23® (IBM, Armonk, NY, USA).

 Results



Patients characteristics

[Figure 1] shows the patients' flow. There were 36 enrolled patients and their characteristics are presented in [Table 1]. The average patient ages at the time of this study and at the time they had received the diagnosis were 26.3 ± 4.7 years (range 20–36) and 4.3 ± 2.1 years (range 0–10), respectively. Five patients with an average age of 23.4 ± 4.7 years were continuing treatment with glucocorticoids until this study period. Noninvasive positive pressure ventilation (NIV) had already been initiated in 32 patients (88.9%), with the average starting age for NIV of 20.3 ± 3.8 years old. Twenty-six patients (72.2%) were able to self-propel their electric wheelchairs. Thirteen patients (36.1%) were able to handwrite questionnaire responses. Most participants lived with family members, but three patients (8.3%) lived alone and utilized the public welfare services such as home caregivers. Fourteen patients (38.9%) were employed. Most patients were receiving either home-visit or outpatient rehabilitation service (61.1% and 80.6%, respectively).{Figure 1}

Activities of daily livings assessed by the Functional Independence Measure

The average scores for total FIM and motor FIM were 53.9 ± 3.4 and 19.0 ± 3.1 points, respectively. The distribution of the motor scores of FIM was 13 (total assistance) to 25 (maximum assistance). Although there was no statistical significance, the scores with individual differences were in the areas of eating (2.4 ± 1.6 points), grooming (1.4 ± 0.7 points), bladder management (1.9 ± 0.4 points), bowel management (1.6 ± 0.5 points), and wheelchair locomotion (3.8 ± 1.5 points) [Table 2].{Table 2}

The Hospital Anxiety and Depression Scale assessment

The average scores and standard deviation for HADS-A (anxiety) and HADS-D (depression) were 4.8 ± 2.8 (maximum 14, minimum 0) points and 2.9 ± 2.5 (maximum 9, minimum 0) points, respectively. Overall, this population did not demonstrate a clinically significant state of anxiety and depression. In terms of individual differences, five patients for HADS-A and two patients for HADS-D demonstrated scores of 8–11 points, which were suggestive of anxiety or a depressive state. One patient had a HADS-A score over 11 points, indicating clinical anxiety. The probable rate of anxiety and depression was 2.8% and 0%, respectively.

The SF-36 v2 assessment

As shown in [Table 3], the values of all the domains for SF-36 v2 in study participants were compared to the Japanese standard values. The physical functioning (PF) and role physical (RP) domains in study participants showed statistically significantly lower values of 7.2 ± 16.3 and 70.8 ± 25.8 (P < 0.001), respectively. For all other domains, there were no significant differences between study participants and the Japanese standard population.{Table 3}

The World Health Organization Quality of Life 26 assessment

For the WHOQOL26, the number of patients who responded “very good” or “good” was 20 (55.6%) for Item 1 and 21 (58.3%) for Item 2, respectively. The domains of psychological, social relationships, environmental, and total were higher than age-adjusted values of the Japanese national norm, with a statistically significant difference (P < 0.001) for the environmental domain. For study participants, the score for the physical health domain (3.33 ± 0.51) was slightly lower than the Japanese national norm (3.39 ± 0.57, P = 0.639).

Correlation among the scores of the Functional Independence Measure, Hospital Anxiety and Depression Scale, SF-36 v2, and World Health Organization Quality of Life 26

As shown in [Figure 2], no significant correlation was found for the FIM scores (total, motor, and cognitive) with the scores of HADS-A and HADS-D, the subscales of SF-36 v2, and the domains of the WHOQOL26. The FIM scores did not considerably affect the psychological distress, HRQOL, and global QOL. However, for the scores of the HADS-A among SF-36 v2 and WHOQOL26, the Spearman's correlation was detected in the subscales of GH (ρ = −0.39, P < 0.05) and social functioning (SF) (ρ = −0.49, P < 0.01) for the SF-36 v2, and the physical (ρ = −0.343, P < 0.05), psychological (ρ = −0.584, P < 0.01), social relationships (ρ = −0.448, P < 0.01), and total (ρ = −0.402, P < 0.05) domain of WHOQOL26. The HADS-D was moderately negatively correlated with SF-36 v2 domains of RP (ρ = −0.495 P < 0.01), bodily pain (BP) (ρ = −0.516, P < 0.01), GH (ρ = −0.377, P < 0.05), vitality (VT) (ρ = −0.711, P < 0.01), role emotional (RE) (ρ = −0.451, P < 0.01), and mental health (MH) (ρ = −0.414, P < 0.05). The HADS-D was also moderately negatively correlated with the WHOQOL26 domains of physical (ρ = −0.436, P < 0.01), psychological (ρ = −0.394, P < 0.05), and total (ρ = −0.424, P < 0.05). The multivariate analysis showed that independent demographic characteristic factors, such as age, glucocorticoid treatment status, initiated NIV, gastrostomy, or family structure did not correlate with the scores of FIM, HADS, SF-36 v2, or WHOQOL-26.{Figure 2}

 Discussion



This study has identified physical and psychosocial features of a part of the population of Japanese adults with DMD. Skill levels of ADLs were not significantly correlated with depression, anxiety, HRQOL, and global QOL. Unlike the recent study,[18] using the FIM scores, individual differences in gross and fine motor skills for adults with DMD can be roughly assessed. For the scores of total and motor FIM, even though most of the study participants needed anywhere from total assistance to maximum assistance for ADLs with significantly reduced physical domains of HRQOL, the existence of psychological distress in this population was found to be in the normal range without clinical depression and anxiety. A previous study revealed that seven Japanese adults with DMD (average age of 37.3 years old) felt anxiety and worry when they became wheelchair and respirator dependent.[19] For participants in the present study, none of the physical and social characteristics were found to be statistically relevant factors for depression and anxiety, even though all the patients were wheelchair dependent and 31 (88.9%) were using noninvasive ventilators. None of our patients were using tracheostomy with invasive ventilation (TIV); thus, we could not determine whether TIV influenced the development of depression and anxiety. One study revealed that nonambulatory DMD patients had a higher rate of depression than ambulatory patients.[20] A Dutch study of adults with DMD revealed that the average symptom scores of HADS-A and HADS-D were higher, and the average age was older than the population in the present study.[3] Furthermore, 11.4% in the Dutch study received antidepressant medication, fatigue was present in 40.5%, and 73.4% reported BP.[3] In the UK study, the perception of pain in the DMD patient group was significantly higher than in the control group.[18] In the present study, based on the item scores of the SF-36 v2, 75% and 27.7% of patients reported body pain and usual fatigue, respectively. Therefore, the existence of depression could be suggested as causes for the difference in the prevalence of psychological distress between the Dutch and current studies.

In the SF-36 v2 results for the current study, the PF and RF domain scores were significantly lower than the national standard value of Japanese which was similar to results obtained from several other studies.[3],[11],[18],[21],[22] In Germans with DMD over the age of 18, all the domains of physical scales (PF, RP, BP, and GH) were significantly lower, but SF, RE, and MH in psychological scales showed no difference between study participants and healthy German subjects.[21] In the previously mentioned Dutch study, adults with DMD were compared to a Dutch reference group, the domain of RE was similar in both groups, with a higher score in PF, lower scores in other domains in the patient's group, and BP and VT scores not significantly lower.[3] In the current study results, PF and RP were significantly low; however, domain scores for VT and MH were slightly higher than the Japanese standard norm. These findings were different from the UK study in which all of the domain scores were lower than control subjects.[18] The German study included three patients who were able to walk <50 m, nocturnal ventilation was used in 50% of the subgroup, and 20.8% had a gastrostoma.[21] The Dutch group included participants with severe complication, including 53.2% who needed TIV, 45.6% who needed NIV, and 27.9% with gastrostoma.[3] In addition, 34.1% of participants had already lived in a residential home.[3] From these findings, the different distribution trends in SF-36 domains between the current and previous studies may be caused by the functional severity, seriousness of complications, and different social background among the patients in each study. Interestingly, the current results of WHOQOL26 showed not significant but slightly lower scores of physical health, while the other domain scores were slightly higher than the Japanese national age-adjusted norm with the significance in the environmental domain. In the WHOQOL-BREF result of Taiwanese DMD patients, moderate-to-large impact was noted in the domain of physical health and psychological and social relationships with the significant difference in the domain score of social relationships between younger and older DMD patients.[11] Furthermore, only significant difference was found in social relationships domain in Dutch adult DMD patients compared with the standard norm.[3] When comparing the current results of the SF-36 v2 and the WHOQOL26 to those of previous studies, the domains of PF and physical health were lower than the national standard norm, which was similar to the earlier studies. However, trends in the distribution of other domain scores were unequal to the other countries, perhaps due to the perception that global QOL may also be affected by their functional complication, surrounding culture, and the living situation of the study participants. Similar to the previous study,[3] the PF and RF domains of HRQOL in our patients were markedly affected by their disease; however, their global QOL seems to maintain as much as similar degree to age-adjusted healthy Japanese subjects.

In this study, to clarify whether the skill levels of ADLs may have a potential impact among psychological distress, HRQOL, and global QOL, we examined the significance of correlation among the FIM, HADS, SF-36 v2, and WHOQOL26. However, no conspicuous correlation was found similar to the recent study.[18] A study in Taiwanese individuals with DMD showed that the basic ADLs score had a moderate correlation among the domains of PF and SF on the SF-36 v2, and correlated between the domains of social relationships of the WHOQOL-BREF.[11] This differed from the results of the current study. A possible cause for this difference was the average age in the current study, which was higher than the study group.[11] In addition, the current study used the FIM for the evaluation of ADLs, which was not a specific measure for MD. It differed from the study where they used one domain from the scale that they designed particularly for patients with MD. Fujiwara et al. reported that the mean FIM motor score for Japanese individuals with DMD over 15 years old was 28.3 (ranging from 14 to approximately 50),[23] while our result was 19.0 with very low variation (ranging from 13 to 25). This means that the distribution of the motor FIM scores of participants in the current study is not varied [Table 2]. Correlation between factors is difficult to detect in data with low variation, such as FIM score in the current study. An Italian study assessed 48 ventilated adults with DMD using the individualized neuromuscular QOL, which was developed as a specialized measurement tool to assess HRQOL in patients with muscular diseases. Their results showed poor QOL, with the weakest domains being physical health and area of life, while the psychosocial domain was not as weak.[24] Even though not all participants in our study used NIV, the distribution tendency of the HRQOL domain obtained nearly the same results as that of the Italian study. In addition, Otto et al. showed that HRQOL was not significantly associated with the age of disease onset.[25] Although people with serious health conditions with persistent disabilities and impairments can experience good QOL, Albrecht and Devlieger described these individuals with the phrase “disability paradox.”[26] Disability paradox in individuals with DMD was mentioned by Pangalila[27] and seen in a multinational study.[4] It has been described that patients in the early stage of DMD show a “response shift,” wherein individuals who confront such health changes, the criteria for judging answers for QOL or patient-reported outcome measures are changing.[28] This phenomenon may enable them to experience high QOL.[27]

Even our study detected the disability paradox of psychological disability and HRQOL in study participants as well as in a precedence study.

Some limitations exist in the study. First, the personality traits of patients may present some bias. Consented patients may be more curious and motivated to try unfamiliar activities. Second, to use the validated questionnaires to investigate mental status and QOL, patients were excluded who were unable to comprehend the contents and answer the questions. Furthermore, the examiner asking the patients the questions and their responses being recorded by the examiner might have influenced the answers. Third, the gene abnormalities of each patient were not considered in this study. It is reported that part of the mutation affects the neuropsychological recognition of a patient's traits, psychological status, and recognition for their QOL.[29] Further study is needed to evaluate methods other than questionnaires to assess psychosocial factors impacting adults with DMD and to examine the types and parts of gene mutations that may affect the perception of psychological distress and QOL. This study demonstrated physical, social, and psychological characteristics of a part of the population of Japanese adults with DMD. Even if our patients' ADLs levels were almost dependent on the others, our results show that their mental status and QOL could be maintained in favorable conditions without severe perception of anxiety, depression, and pain. Since DMD is an intractable rare disease, there are not many studies focusing only on adults.[3],[18] The results of the current study provide meaningful information for Japanese adults with DMD and their caregivers. Moreover, physicians should consider not only maintaining physical functions of patients but also promoting social participation in consideration of the patients' respiratory and cardiac conditions.

 Conclusion



This study investigated the physical and psychosocial characteristics of a part of the Japanese population of adults with DMD. Almost all study participants required assistance with ADLs, with slight individual differences. The skill levels of ADLs had no statistically significant correlation with anxiety, depression, HRQOL, and global QOL. Furthermore, no significant correlations were found for the physical and social characteristics of patients among psychological distress and QOL.

Financial support and sponsorship

This research was supported by the Intramural Research Grant (29-3) for Neurological and Psychiatric Disorders of NCNP.

Conflicts of interest

There are no conflicts of interest.

References

1Birnkrant DJ, Bushby K, Bann CM, Case LE, Clemens PR, Cripe L, et al., Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 2018;17:251-67.
2Andrews JG, Wahl RA. Duchenne and Becker muscular dystrophy in adolescents: current perspectives. Adolesc Health Med Ther 2018;9:53-63.
3Pangalila RF, van den Bos GA, Bartels B, Bergen M, Stam HJ, Roebroeck ME. Prevalence of fatigue, pain, and affective disorders in adults with duchenne muscular dystrophy and their associations with quality of life. Arch Phys Med Rehabil 2015;96:1242-7.
4Landfeldt E, Lindgren P, Bell CF, Guglieri M, Straub V, Lochmüller H, et al. Health-related quality of life in patients with Duchenne muscular dystrophy: A multinational, cross-sectional study. Dev Med Child Neurol 2016;58:508-15.
5Uchikawa K, Liu M, Hanayama K, Tsuji T, Fujiwara T, Chino N. Functional status and muscle strength in people with Duchenne muscular dystrophy living in the community. J Rehabil Med 2004;36:124-9.
6van der Putten JJ, Hobart JC, Freeman JA, Thompson AJ. Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel index and the Functional Independence Measure. J Neurol Neurosurg Psychiatry 1999;66:480-4.
7Prodinger B, O'Connor RJ, Stucki G, Tennant A. Establishing score equivalence of the functional independence measure motor scale and the barthel index, utilising the international classification of functioning, disability and health and rasch measurement theory. J Rehabil Med 2017;49:416-22.
8Haigh R, Tennant A, Biering-Sørensen F, Grimby G, Marincek C, Phillips S, et al. The use of outcome measures in physical medicine and rehabilitation within Europe. J Rehabil Med 2001;33:273-8.
9Cohen ME, Marino RJ. The tools of disability outcomes research functional status measures. Arch Phys Med Rehabil 2000;81:S21-9.
10Kitamura T. Hospital anxiety and depression scale. Seisin Sindangaku 1993;4:371-2.
11Lue YJ, Chen SS, Lu YM. Quality of life of patients with duchenne muscular dystrophy: From adolescence to young men. Disabil Rehabil 2017;39:1408-13.
12Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
13The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998;28:551-8.
14Huang IC, Wu AW, Frangakis C. Do the SF-36 and WHOQOL-BREF measure the same constructs? Evidence from the Taiwan population*. Qual Life Res 2006;15:15-24.
15WHOQOL Group. Development of WHOQOL: Rational and current status. Int J Ment Health 1994;23:24-56.
16Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol 1998;51:1037-44.
17Tazaki M, Nakane Y, Endo T, Kakikawa F, Kano K, Kawano H, et al. Results of a qualitative and field study using the WHOQOL instrument for cancer patients. Jpn J Clin Oncol 1998;28:134-41.
18Jacques MF, Stockley RC, Onambele-Pearson GL, Reeves ND, Stebbings GK, Dawson EA, et al. Quality of life in adults with muscular dystrophy. Health Qual Life Outcomes 2019;17:121.
19Fujino H, Iwata Y, Saito T, Matsumura T, Fujimura H, Imura O. The experiences of patients with Duchenne muscular dystrophy in facing and learning about their clinical conditions. Int J Qual Stud Health Well-being 2016;11:32045.
20Latimer R, Street N, Conway KC, James K, Cunniff C, Oleszek J, et al. Secondary conditions among males with duchenne or becker muscular dystrophy. J Child Neurol 2017;32:663-70.
21Elsenbruch S, Schmid J, Lutz S, Geers B, Schara U. Self-reported quality of life and depressive symptoms in children, adolescents, and adults with duchenne muscular dystrophy: A cross-sectional survey study. Neuropediatrics 2013;44:257-64.
22Kohler M, Clarenbach CF, Boni L, Brack T, Russi EW, Bloch KE. Quality of life, physical disability, and respiratory impairment in duchenne muscular dystrophy. Am J Respir Crit Care Med 2005;172:1032-36.
23Fujiwara T, Tanabe A, Uchikawa K, Tsuji T, Tanuma A, Hase K, et al. Activities of daily living (ADL) structure of patients with duchenne muscular dystrophy, including adults. Keio J Med 2009;58:223-6.
24Crescimanno G, Greco F, D'Alia R, Messina L, Marrone O. Quality of life in long term ventilated adult patients with Duchenne muscular dystrophy. Neuromuscul Disord 2019;29:569-75.
25Otto C, Steffensen BF, Højberg AL, Barkmann C, Rahbek J, Ravens-Sieberer U, et al. Predictors of health-related quality of life in boys with duchenne muscular dystrophy from six European countries. J Neurol 2017;264:709-23.
26Albrecht GL, Devlieger PJ. The disability paradox: High quality of life against all odds. Soc Sci Med 1998;48:977-88.
27Pangalila R. Quality of life in Duchenne muscular dystrophy: The disability paradox. Dev Med Child Neurol 2016;58:435-6.
28Schwartz CE. Applications of response shift theory and methods to participation measurement: A brief history of a young field. Arch Phys Med Rehabil 2010;91:S38-43.
29Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Colvin MK, et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: Primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol 2018;17:445-55.